Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines.

Martello LA, McDaid HM, Regl DL, Yang CP, Meng D, Pettus TR, Kaufman MD, Arimoto H, Danishefsky SJ, Smith AB 3rd, Horwitz SB.

Clin Cancer Res. 2000 May;6(5):1978-87.

2.

Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.

Kavallaris M, Kuo DY, Burkhart CA, Regl DL, Norris MD, Haber M, Horwitz SB.

J Clin Invest. 1997 Sep 1;100(5):1282-93.

3.

Development of two radioimmunoassays to detect paclitaxel in sera and in cerebrospinal, ascitic, and pleural fluids.

O'Boyle KP, Wang Y, Schwartz EL, Regl DL, Einzig A, Dutcher JP, Wiernik PH, Horwitz SB.

Cancer. 1997 Mar 1;79(5):1022-30.

PMID:
9041166
4.

Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance.

Haber M, Burkhart CA, Regl DL, Madafiglio J, Norris MD, Horwitz SB.

J Biol Chem. 1995 Dec 29;270(52):31269-75.

Supplemental Content

Support Center